This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. Just because implantable defibrillators have been found to prevent ...

Among patients with advanced HFrEF, women, compared with men, are less likely to receive an implantable cardiac defibrillator. Women who have advanced heart failure with reduced ejection fraction ...

Results from Optimizing Beta-Blocker Dosage in Female Patients Using the Wearable Cardioverter Defibrillator (OPT-BB Women) were presented at ESC-HF 2026 ZOLL®, an Asahi Kasei company that ...

Cardiopulmonary resuscitation (CPR) and defibrillation are crucial life-saving techniques that can greatly influence survival rates during emergencies involving sudden cardiac arrest (SCA). The ...

Despite advances in defibrillation technology, shock-refractory ventricular fibrillation remains common during out-of-hospital cardiac arrest. Double sequential external defibrillation (DSED; rapid ...

ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that insights from the LifeVest® wearable cardioverter defibrillator (WCD) helped physicians ...